Transfusion Practice and Blood Products

Transfusion practice is the branch of laboratory and clinical medicine concerned with collecting, processing, testing, storing, and administering human blood and its derived components. It spans the blood bank — where whole-donor blood is separated into red cells, plasma, platelets, and cryoprecipitate — and the bedside, where these products are matched to patients and given for defined indications while adverse effects are monitored.

Definition

Transfusion practice is the integrated set of laboratory and clinical activities by which blood components are prepared, qualified as safe, selected for compatibility, and administered to patients, together with the appraisal of when transfusion is warranted and how its risks are minimised.

Scope

This area orients the reader to the chain that links a blood donor to a transfused patient: component manufacture and storage, the indications for and alternatives to transfusion, the management of massive haemorrhage, the special considerations of vulnerable patient groups, and the screening that keeps the supply safe. It is a reference overview of how transfusion is organised and reasoned about, not a protocol for prescribing blood.

Sub-topics

• Blood-Component Preparation, Preservation, and Storage (Red Cells, Plasma, Platelets, Cryoprecipitate)
• Infectious Disease Testing and Pathogen Reduction in Blood Banking
• Massive Transfusion Protocols, Trauma-Induced Coagulopathy, and Damage-Control Resuscitation
• Transfusion in Special Populations (Pregnancy, Neonates, Immunocompromised)
• Transfusion Indications, Restrictive Transfusion Practice, and Alternatives to Allogenic Blood

Core questions

• How is donated whole blood separated, preserved, and stored as distinct therapeutic components?
• When does the evidence support transfusion, and what alternatives can reduce exposure to allogeneic blood?
• How is life-threatening haemorrhage managed with balanced blood-product resuscitation?
• What additional safeguards apply when transfusing neonates, pregnant patients, and immunocompromised recipients?
• How does donor screening and testing keep transfusion-transmitted infection rare?

Key concepts

• Blood component (red cells, plasma, platelets, cryoprecipitate)
• Restrictive versus liberal transfusion thresholds
• Patient blood management
• Massive transfusion and balanced resuscitation
• Transfusion-transmitted infection
• Haemovigilance

Mechanisms

A unit of whole blood is separated by centrifugation into components that can each be stored under conditions matched to the cells or proteins they contain, so a single donation can serve several recipients. Before release, donations are screened for transfusion-transmissible infections and the recipient's blood is typed and tested for compatibility. At the bedside, the decision to transfuse weighs the physiological deficit (oxygen-carrying capacity, coagulation factors, or platelets) against the recognised hazards of transfusion, an appraisal that has shifted toward restrictive thresholds as randomised evidence has accumulated (carson-2017, carson-2016). The residual harms — immune-mediated reactions, lung injury, circulatory overload, and rare infection — are tracked through haemovigilance (vamvakas-2009).

Clinical relevance

Transfusion is among the most common procedures in hospital care, and an understanding of how components are produced, indicated, and made safe underlies sound use of a finite donated resource. This overview describes how the field is structured and how its evidence is generated; it is not a basis for individual prescribing, dosing, or treatment decisions, which depend on patient-specific assessment and current institutional protocols.

Evidence & guidelines

Large randomised trials comparing restrictive and liberal transfusion thresholds, together with synthesising guidelines such as the AABB recommendations, form the evidence backbone of contemporary practice (carson-2016, carson-2017). The detailed trials and guidance specific to each subtopic are presented in the child topics.

History

Safe transfusion became possible after the discovery of the ABO blood groups in the early twentieth century and the development of anticoagulant-preservative solutions that allowed blood to be stored. The separation of whole blood into components, the introduction of systematic infectious-disease screening, and — more recently — the move toward evidence-based restrictive use and patient blood management have progressively reshaped the field (klein-2007).

Seminal works

• carson-2017
• carson-2016
• vamvakas-2009

Frequently asked questions

Why is whole blood usually separated into components?

Separation lets each part of a donation be stored under optimal conditions and given only to patients who need that specific component, so one donation can help several recipients and unnecessary exposure is avoided.

Is transfusion practice the same as immunohematology?

They overlap but are distinct: immunohematology is the laboratory science of blood-group antigens and antibodies and compatibility testing, while transfusion practice is the broader activity of producing, indicating, and safely administering blood products.